NCT04047862 2025-08-22
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
BeiGene
Phase 1 Completed
BeiGene
UCB Pharma
Gilead Sciences
Eli Lilly and Company
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)